USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	051574/0498			Pages:	8
		Recorded:	01/13/2020
Attorney Dkt #:	MEREO ONCOMED KREOS
Conveyance:	RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).

Total properties: 16

Patent #:	7750124	Issue Dt:	07/06/2010	Application #:	11905392	Filing Dt:	09/28/2007
Publication #:	US20080187532	Pub Dt:	08/07/2008
Title:	ANTI-HUMAN DLL4 ANTIBODIES AND COMPOSITIONS

Patent #:	9067986	Issue Dt:	06/30/2015	Application #:	12768650	Filing Dt:	04/27/2010
Publication #:	US20110123532	Pub Dt:	05/26/2011
Title:	Method for Making Heteromultimeric Molecules

Patent #:	9376497	Issue Dt:	06/28/2016	Application #:	12782429	Filing Dt:	05/18/2010
Publication #:	US20100316637	Pub Dt:	12/16/2010
Title:	COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER

Patent #:	8551479	Issue Dt:	10/08/2013	Application #:	13229006	Filing Dt:	09/09/2011
Publication #:	US20120070438	Pub Dt:	03/22/2012
Title:	Methods for Treating Melanoma

Patent #:	8883145	Issue Dt:	11/11/2014	Application #:	13501944	Filing Dt:	06/26/2012
Publication #:	US20120263721	Pub Dt:	10/18/2012
Title:	METHODS OF TREATMENT WITH DLL4 ANTAGONISTS AND AN ANTI-HYPERTENSIVE AGENT

Patent #:	8858941	Issue Dt:	10/14/2014	Application #:	13625417	Filing Dt:	09/24/2012
Publication #:	US20130164295	Pub Dt:	06/27/2013
Title:	VEGF/DLL4 Binding Agents and Uses Thereof

Patent #:	9309311	Issue Dt:	04/12/2016	Application #:	13801189	Filing Dt:	03/13/2013
Publication #:	US20130253172	Pub Dt:	09/26/2013
Title:	Method for Making Heteromultimeric Molecules

Patent #:	9228020	Issue Dt:	01/05/2016	Application #:	13826103	Filing Dt:	03/14/2013
Publication #:	US20140147443	Pub Dt:	05/29/2014
Title:	COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER

Patent #:	9480744	Issue Dt:	11/01/2016	Application #:	14020567	Filing Dt:	09/06/2013
Publication #:	US20140065149	Pub Dt:	03/06/2014
Title:	Methods for Treating Melanoma

Patent #:	9599620	Issue Dt:	03/21/2017	Application #:	14068910	Filing Dt:	10/31/2013
Publication #:	US20140220001	Pub Dt:	08/07/2014
Title:	Methods and Monitoring of Treatment with a DLL4 Antagonist

Patent #:	9511139	Issue Dt:	12/06/2016	Application #:	14498602	Filing Dt:	09/26/2014
Publication #:	US20150118232	Pub Dt:	04/30/2015
Title:	Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent

Patent #:	9914771	Issue Dt:	03/13/2018	Application #:	15059668	Filing Dt:	03/03/2016
Publication #:	US20160280774	Pub Dt:	09/29/2016
Title:	Method for Making Heteromultimeric Molecules

Patent #:	9574009	Issue Dt:	02/21/2017	Application #:	15163301	Filing Dt:	05/24/2016
Publication #:	US20160362499	Pub Dt:	12/15/2016
Title:	Polynucleotides Encoding VEGF/DLL4 Binding Agents

Patent #:	9982042	Issue Dt:	05/29/2018	Application #:	15336272	Filing Dt:	10/27/2016
Publication #:	US20170166632	Pub Dt:	06/15/2017
Title:	Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent

Patent #:	9879084	Issue Dt:	01/30/2018	Application #:	15401543	Filing Dt:	01/09/2017
Publication #:	US20170183406	Pub Dt:	06/29/2017
Title:	Modified Immunoglobulin Molecules That Specifically Bind Human VEGF and DLL4

Assignor

Exec Dt:

01/13/2020

Assignee

800 CHESAPEAKE DRIVE

REDWOOD CITY, CALIFORNIA 94063

Correspondence name and address
	JESSICA WOLFF
	4510 PARK DR
	CARLSBAD, CA 92008

Search Results as of: 06/06/2024 07:53 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6